10 February 2026 - Top Stories

Australia’s health tech scene is tilting toward modular EMRs and disciplined AI adoption, with real‑world testing becoming a priority for scale.

Dedalus has emerged as a leading player in the Australian EMR market, topping Black Book Market Research’s 2026 evaluation across 18 strategic criteria. Stakeholders highlighted strong medication safety capabilities, solid links to patient administration systems and pharmacy workflows, and open standards that foster value from cost to partnerships. The ORBIS EMR, now introduced to Australia from Dedalus’s European base as a cloud‑enabled, modular option, sits alongside webPAS and MedChart, offering a lower‑disruption upgrade path for hospitals moving toward interoperability and AI‑ready data.

The broader health‑tech narrative in Australia is increasingly about how to implement AI safely in real care settings. Digital Health Week 2026 featured Professor Peter Steele from the University of Melbourne advocating a front‑end Learning Health System approach. In this model, tools are tested in routine care, measured in real time, and only scaled if they deliver durable clinical or operational value. Framed as LHS 2.0, the idea is to balance transformation with ongoing cost control while building governance that supports responsible AI deployment.

Meanwhile, the broader AI safety conversation crossed into consumer guidance. A study from the University of Oxford, published in Nature Medicine, found that while large language models perform well on standard tests, they can give inaccurate or inconsistent medical guidance for real patients. The takeaway for Australian healthtech leaders is clear: consumer AI in health requires robust safety standards and real‑world validation before widespread deployment.

On the data‑driven front, interim assessments of urgent care clinics suggest potential ED relief, with unit costs around A$216 per presentation and modelling indicating up to hundreds of thousands of ED visits could be impacted annually. The findings emphasise the value of analytics and triage tooling in shaping how digital health services redirect demand and measure outcomes, even as data gaps call for ongoing evaluation ahead of a final 2026 report.

Taken together, the week’s signals point to a tougher, more disciplined path for health AI in Australia: choose interoperable EMRs, build front‑end testing grounds for AI, enforce safety standards, and rely on data analytics to quantify real value.

• Dedalus leads AU EMR rankings; ORBIS enters AU as cloud, modular option for interoperable upgrades.
• Open standards and strong PAS/pharmacy integration seen as essential in EMR vetting.
• Learning Health System framework encourages real‑world AI testing before scaling.
• Oxford LLM study underscores need for rigorous safety standards in consumer medical AI.
• Urgent care pilots suggest AI‑driven triage and analytics can influence ED demand data.
• Australia-focused data governance and interoperability shape vendor selection and investment decisions.
• Real‑world measurement and cost discipline likely to guide AI rollout in health systems.